Read More Medical Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Apr 16, 2025
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
Read More Medical More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 04, 2025
Read More Apparatus Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer! Apr 01, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Apr 06, 2025